Abbott’s Xience Drug-Eluting Stent Rapidly Gaining Market Share In Europe
This article was originally published in The Gray Sheet
Executive Summary
Abbott Laboratories' Xience V drug-eluting stent has steadily gained market share since its European launch last year, the company says